Browse Pet Safety Reports
18,026 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,026 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,026 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jul 11, 2017 | Cat | Domestic Shorthair | Selamectin | Alopecia; Itching | Outcome Unknown |
| Jul 11, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia | Outcome Unknown |
| Jul 10, 2017 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site alopecia; Application site scab; Application site itching; O... | Ongoing |
| Jul 10, 2017 | Dog | Shepherd Dog - German | Milbemycin Oxime, Lufenuron | Swollen feet; Reddening of the skin; Localised pain NOS (see other 'SOCs' for... | Recovered/Normal |
| Jul 10, 2017 | Dog | Dog (unknown) | Imidacloprid; Moxidectin | Application site pruritus; Application site erythema; Application site alopecia | Outcome Unknown |
| Jul 9, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia | Outcome Unknown |
| Jul 9, 2017 | Cat | Bengal | Selamectin | Application site alopecia; Application site inflammation; Application site ir... | Outcome Unknown |
| Jul 9, 2017 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Application site alopecia; Alopecia local; Behavioural disorder NOS | Outcome Unknown |
| Jul 8, 2017 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Application site alopecia | Outcome Unknown |
| Jul 8, 2017 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Application site pruritus; Application site alopecia; Application site erythema | Outcome Unknown |
| Jul 7, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Skin inflammation NOS; Erythema (for urticaria see... | Ongoing |
| Jul 7, 2017 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Application site alopecia | Outcome Unknown |
| Jul 7, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Application site irritation | Outcome Unknown |
| Jul 6, 2017 | Dog | Retriever - Labrador | Rabacfosadine Succinate | Erythema (for urticaria see Immune SOC); Dermatosis NOS; Alopecia | Ongoing |
| Jul 6, 2017 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Lethargy (see also Central nervous system depression in 'Neurological'); Appl... | Recovered/Normal |
| Jul 6, 2017 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Application site alopecia; Application site mucopurulent discharge | Recovered/Normal |
| Jul 6, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia | Outcome Unknown |
| Jul 6, 2017 | Dog | Retriever - Golden | Afoxolaner | Alopecia local; Hyperpigmentation | Recovered/Normal |
| Jul 6, 2017 | Dog | Shih Tzu | Rabacfosadine Succinate | Alopecia general; Lack of efficacy - NOS; Pyoderma; Death; Pustules; Seborrho... | Died |
| Jul 5, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Application site lesion; Application site reaction... | Ongoing |
| Jul 5, 2017 | Dog | Terrier (unspecified) | Rabacfosadine Succinate | Decreased appetite; Alopecia NOS; Hyperpigmentation; Skin lesion NOS | Recovered/Normal |
| Jul 4, 2017 | Dog | Chihuahua | Selamectin | Application site reddening; Application site alopecia; Application site skin ... | Ongoing |
| Jul 3, 2017 | Cat | Cat (other) | Selamectin | Application site alopecia; Application site inflammation | Ongoing |
| Jul 3, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Behavioural disorder NOS | Outcome Unknown |
| Jul 2, 2017 | Dog | Pointing Dog - German Short... | Afoxolaner | Alopecia local; Erythema (for urticaria see Immune SOC) | Outcome Unknown |
| Jul 2, 2017 | Cat | Siamese | Selamectin | Application site alopecia; Application site inflammation | Outcome Unknown |
| Jul 2, 2017 | Cat | Domestic Mediumhair | Selamectin | Application site alopecia; Application site inflammation | Outcome Unknown |
| Jul 1, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Application site inflammation; Application site we... | Outcome Unknown |
| Jul 1, 2017 | Dog | Retriever - Labrador | Sarolaner | Lethargy (see also Central nervous system depression in 'Neurological'); Alop... | Ongoing |
| Jul 1, 2017 | Cat | Domestic Mediumhair | Praziquantel; Emodepside | Application site alopecia | Outcome Unknown |
| Jul 1, 2017 | Cattle | Holstein-Friesian also know... | Monensin Sodium | Diarrhoea; Lethargy (see also Central nervous system depression in 'Neurologi... | Ongoing; Died |
| Jul 1, 2017 | Dog | Cattle Dog - Australian (bl... | Afoxolaner | Panting; Tachycardia; Skin warmth; Scratching; Alopecia local | Ongoing |
| Jul 1, 2017 | Dog | Boxer (German Boxer) | Trilostane | Laceration; Tongue ulceration; Head tilt - neurological disorder; Muscle wast... | Outcome Unknown |
| Jul 1, 2017 | Cat | Domestic Mediumhair | Selamectin | Application site alopecia | Outcome Unknown |
| Jul 1, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia | Outcome Unknown |
| Jul 1, 2017 | Cat | Domestic Shorthair | Selamectin | Application site reaction NOS; Skin sore; Pruritus; Application site alopecia | Outcome Unknown |
| Jun 30, 2017 | Dog | Terrier - Jack Russell | Afoxolaner | Pruritus; Alopecia | Ongoing |
| Jun 30, 2017 | Dog | Crossbred Canine/dog | Afoxolaner 68 Mg Chewable Tablets | Diarrhoea; Pruritus; Alopecia general | Outcome Unknown |
| Jun 30, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Application site scab; Application site irritation | Ongoing |
| Jun 30, 2017 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site alopecia; Application site scab | Ongoing |
| Jun 30, 2017 | Dog | Dachshund (unspecified) | Imidacloprid; Moxidectin | Lethargy (see also Central nervous system depression in 'Neurological'); Puru... | Recovered/Normal |
| Jun 29, 2017 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Application site alopecia; Application site ulcer | Recovered/Normal |
| Jun 28, 2017 | Dog | Collie - Border | Afoxolaner | Alopecia | Outcome Unknown |
| Jun 28, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia | Ongoing |
| Jun 27, 2017 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site skin change NOS; Localised oedema (not application site); Alop... | Ongoing |
| Jun 26, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Application site blister | Ongoing |
| Jun 26, 2017 | Dog | Retriever - Labrador | Afoxolaner | Greasy skin; Alopecia local; Pruritus | Outcome Unknown |
| Jun 26, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia | Outcome Unknown |
| Jun 26, 2017 | Cat | Domestic Shorthair | Selamectin | Application site alopecia; Excessive thirst; Lethargy (see also Central nervo... | Outcome Unknown |
| Jun 24, 2017 | Cat | Domestic Mediumhair | Imidacloprid; Moxidectin | Application site erythema; Application site alopecia; Application site irrita... | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.